Tower Research Capital LLC (TRC) - AMNEAL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19,661
-43.2%
4,659
-58.3%
0.00%0.0%
Q2 2023$34,611
+494342.9%
11,165
+120.0%
0.00%
Q1 2023$7
-58.8%
5,076
-39.9%
0.00%
-100.0%
Q4 2022$17
-99.9%
8,439
+14.6%
0.00%
Q3 2022$15,000
-31.8%
7,362
+7.0%
0.00%
Q2 2022$22,000
+144.4%
6,878
+192.8%
0.00%
Q1 2022$9,000
-30.8%
2,349
-10.5%
0.00%
Q4 2021$13,000
-75.9%
2,624
-74.1%
0.00%
-100.0%
Q3 2021$54,000
-30.8%
10,115
-33.2%
0.00%
-50.0%
Q2 2021$78,000
+16.4%
15,143
+52.1%
0.00%
+100.0%
Q1 2021$67,000
-65.6%
9,959
-76.7%
0.00%
-83.3%
Q4 2020$195,000
-63.9%
42,670
-69.4%
0.01%0.0%
Q3 2020$540,000
+223.4%
139,332
+296.6%
0.01%
-14.3%
Q2 2020$167,000
+943.8%
35,129
+549.0%
0.01%
+600.0%
Q3 2019$16,000
-71.4%
5,413
-30.3%
0.00%
-75.0%
Q2 2019$56,000
+366.7%
7,766
+790.6%
0.00%
+300.0%
Q1 2019$12,000
-47.8%
872
-48.7%
0.00%
-50.0%
Q4 2018$23,0001,7000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders